Purchase Order 75F40124P00270
- Not listed
- The Food and Drug Administration awarded a delivery order valued at $74,578.42 to Remel Inc. (doing business as Thermo Fisher Scientific Remel Products) on January 13, 2025, for National Antimicrobial Resistance Monitoring System (NARMS) supplies. This is a firm fixed-price delivery order with no small business set-aside, with performance to be completed by May 31, 2025, at Remel's facility in Lenexa, Kansas. The award is issued under the FDA's larger $2.5 million indefinite delivery contract...
- The Food and Drug Administration awarded a delivery order to Remel Inc. (doing business as Thermo Fisher Scientific Remel Products) on April 7, 2026, for various Remel supplies compatible with Sensititre antimicrobial susceptibility testing equipment. The order carries a ceiling value of $25,958.58 and is scheduled for completion by June 2, 2026, with performance taking place in Silver Spring, Maryland. This delivery order represents a child action under the FDA's larger $2.5 million...
- Remel Inc., doing business as Thermo Fisher Scientific Remel Products, was awarded a $131,525.36 firm fixed-price purchase order by the Office of Administrative Services Procurement Management Branch on September 27, 2017, with an ultimate completion date of April 15, 2018. The contract procures antimicrobial susceptibility testing (AST) supplies for laboratory testing operations in Athens, Georgia. No small business set-aside designation was utilized in this award, consistent with Remel's...
- The Food and Drug Administration issued a delivery order on April 13, 2026, to Remel Inc. (doing business as Thermo Fisher Scientific Remel Products) for various Remel supplies compatible with Sensititre equipment with a ceiling value of $54,189.11 and a completion date of July 30, 2026. This is a child order issued under the FDA's existing $2.5 million indefinite delivery contract with Remel, which expires March 20, 2026. The supplies will support the FDA's National Antimicrobial Resistance...
- This federal contract award to Remel Inc., doing business as Thermo Fisher Scientific Remel Products, is for the provision of supplies to the U.S. Food and Drug Administration (FDA) for the National Antimicrobial Resistance Monitoring System (NARMS) and other programs. The firm-fixed-price delivery order, valued at $101,150.05, does not have a small business set-aside designation. Remel Inc. is a for-profit manufacturer of microbiology laboratory products and diagnostic test kits, and a...
- This federal contract award, valued at $68,046.25, was issued by the Food and Drug Administration (FDA) to Remel Inc., a subsidiary of Thermo Fisher Scientific that manufactures microbiology laboratory products and diagnostic test kits. The contract is for the FY24 delivery of various NARMS (National Antimicrobial Resistance Monitoring System) REMEL supplies compatible with SENSITITRE equipment at two locations. This is a firm-fixed-price delivery order contract with a completion date of...
- Remel Inc., operating as Thermo Fisher Scientific Remel Products, received a delivery order award from the Office of Administrative Services Procurement Management Branch on December 7, 2022, for antimicrobial susceptibility testing (AST) supplies. The contract carries a ceiling value of $55,137.08 under a firm fixed-price delivery order structure, with an ultimate completion date of March 31, 2023. The place of performance is located in Lenexa, Kansas, where Remel maintains its headquarters...
- This federal contract award, valued at $46,050.93, was issued by the Food and Drug Administration (FDA) to Remel Inc., a subsidiary of Thermo Fisher Scientific. The contract is a Delivery Order under the IDIQ 75F40122D00010, and it provides Task Order 8 for various laboratory supplies manufactured by Remel, including Remel microbiology products and diagnostic test kits. The contract has an ultimate completion date of October 30, 2023, and utilizes a Firm Fixed Price pricing type. No small...
- Remel Inc., operating as Thermo Fisher Scientific Remel Products, received a delivery order for antimicrobial susceptibility testing (AST) supplies supporting the Eastern Laboratory and the National Antimicrobial Resistance Monitoring System (NARMS). The task order, awarded by the Office of Administrative Services Procurement Management Branch on September 6, 2022, carries a ceiling value of $148,626.12 and is structured as a firm fixed price delivery order with an ultimate completion date of...
- The U.S. Office of Administrative Services Procurement Management Branch awarded a $45.2K firm fixed-price purchase order to Remel Inc., doing business as Thermo Fisher Scientific Remel Products, for maintenance agreement services on AST Trek equipment at the Eastern Laboratory in Athens, Georgia. The contract was awarded on July 29, 2021, with an ultimate completion date of July 31, 2022. This maintenance agreement represents a continuation of the government's relationship with Remel, a...
The Food and Drug Administration awarded a $231,883.66 firm fixed-price purchase order to Remel Inc. (doing business as Thermo Fisher Scientific Remel Products) on July 3, 2024, for an annual maintenance agreement covering multiple Trek Sensitire antimicrobial susceptibility testing (AST) systems. The contract extends through August 30, 2029, and will be performed in Laurel, Maryland. This award represents a continuation of the FDA's reliance on Remel's specialized microbiology laboratory support, particularly for the agency's National Antimicrobial Resistance Monitoring System (NARMS) and regulatory science initiatives. No small business set-aside was used in this procurement. Remel Inc., a subsidiary of Thermo Fisher Scientific headquartered in Lenexa, Kansas, is an established supplier of microbiology laboratory products and diagnostic equipment to multiple federal health and research agencies. This maintenance agreement falls under Remel's broader portfolio of service offerings to the FDA, which includes preventative and corrective maintenance, technical support, and software upgrades for Sensitire systems and compatible consumables. The company currently maintains six active indefinite delivery contracts across federal agencies totaling over $6 million in ceiling value, with the FDA's existing $2.5 million indefinite delivery vehicle representing the agency's primary procurement mechanism for Remel products and services supporting antimicrobial resistance surveillance and testing operations.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| P00002 | Other Administrative Action | $0 | 3/5/26 | |
| P00001 | Exercise an Option | $47.2k | 8/14/25 | |
| Not listed | Not listed | $55.2k | 7/3/24 |